Outlook Therapeutics Inc.

NASDAQ: OTLK · Real-Time Price · USD
2.35
-0.08 (-3.29%)
At close: Aug 15, 2025, 3:59 PM
2.39
1.92%
After-hours: Aug 15, 2025, 07:49 PM EDT

Outlook Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
PE Ratio
-1.31 -0.94 -3.92 -6.23
PEG Ratio
0.09 0.04 0.37 0.13
PS Ratio
n/a n/a n/a n/a
PB Ratio
-1.36 -3.83 29.62 71.91
P/FCF Ratio
-1.44 -1.29 -4.57 -6.11
P/OCF Ratio
-1.44 -1.29 -4.57 -6.11
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
-0.41 -2.46 1.25 2.58
Quick Ratio
0.64 0.66 1.39 3.19
Current Ratio
0.64 0.66 1.39 3.19
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
-22.71 -34.06 -42.41 -55.26
Return on Equity
1.03 4.09 -7.56 -11.54
Return on Assets
-2.61 -1.83 -2.32 -2.33
Return on Invested Capital
-4.55 -2.52 -3.19 -3.04
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a